Celcuity (CELC) Free Cash Flow (2016 - 2025)
Celcuity (CELC) posted Free Cash Flow of -$36.5 million for Q4 2025, up 18.84% on a QoQ basis from -$44.9 million in Q3 2025, and down 31.05% year-over-year from -$52.9 million in Q4 2024.
Celcuity (CELC) Free Cash Flow (2016 - 2025) Analysis & Trends
Celcuity's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$36.5 million for Q4 2025.
- Quarterly Free Cash Flow fell 31.05% year-over-year to -$36.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$153.5 million (down 83.39% YoY) and the FY2025 annual result came in at -$153.5 million, down 83.39% from the prior year.
- Free Cash Flow was -$36.5 million for Q4 2025 at Celcuity, up from -$44.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.6 million in Q1 2021 and bottomed at -$44.9 million in Q3 2025.
- A 5-year average of -$17.4 million and a median of -$12.8 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2021 — Free Cash Flow tumbled 384.75% — and 2023, when it grew 14.54%.
- Celcuity's Free Cash Flow stood at -$6.1 million in 2021, then sank by 56.36% to -$9.6 million in 2022, then tumbled by 93.6% to -$18.6 million in 2023, then plunged by 49.8% to -$27.8 million in 2024, then plunged by 31.05% to -$36.5 million in 2025.
- Business Quant data shows CELC's Free Cash Flow at -$36.5 million in Q4 2025, -$44.9 million in Q3 2025, and -$36.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | -36.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.45 Mn |
| Dec 31, 2025 | -36.45 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Jun 30, 2025 | -36.25 Mn |
| Jun 30, 2025 | -36.25 Mn |
| Mar 31, 2025 | -35.91 Mn |
| Mar 31, 2025 | -35.91 Mn |
| Dec 31, 2024 | -27.82 Mn |
| Dec 31, 2024 | -27.82 Mn |
| Sep 30, 2024 | -20.61 Mn |
| Sep 30, 2024 | -20.61 Mn |
| Jun 30, 2024 | -18.13 Mn |
| Jun 30, 2024 | -18.13 Mn |
| Mar 31, 2024 | -17.16 Mn |
| Mar 31, 2024 | -17.16 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.80 Mn |
| Sep 30, 2023 | -12.80 Mn |